Texas Cardiac Arrhythmia Research Foundation

Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion

Phase 3Recruiting2026234 people25 Sept 2026clinicaltrials.gov

NCT01006876

Phase 3Completed20101,584 people3 Nov 2009clinicaltrials.gov